New York Mortgage Trust Declares Fourth Quarter 2015

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New York Mortgage Trust Declares Fourth Quarter 2015 Common Stock Dividend of $0.24 Per Share, and Preferred Stock Dividends

NEW YORK, Dec. 16, 2015 (GLOBE NEWSWIRE) -- New York Mortgage Trust, Inc. (Nasdaq: NYMT ) (the “Company”) announced today that its Board of Directors declared a regular quarterly cash dividend of $0.24 per share on shares of its common stock for the quarter ending December 31, 2015. The dividend will be payable on January 25, 2016 to common stockholders of record as of December 28, 2015.

In accordance with the terms of the 7.75% Series B Cumulative Redeemable Preferred Stock (“Series B Preferred Stock”) of the Company, the Board of Directors declared a Series B Preferred Stock cash dividend of $0.484375 per share of Series B Preferred Stock for the quarterly period that began on October 15, 2015 and ends on January 14, 2016.  This dividend is payable on January 15, 2016 to holders of record of Series B Preferred Stock as of January 1, 2016. 

In accordance with the terms of the 7.875% Series C Cumulative Redeemable Preferred Stock ("Series C Preferred Stock") of the Company, the Board of Directors declared a Series C Preferred Stock cash dividend of $0.4921875 per share of Series C Preferred Stock for the quarterly period that began on October 15, 2015 and ends on January 14, 2016. This dividend is payable on January 15, 2016 to holders of record of Series C Preferred Stock as of January 1, 2016.

About New York Mortgage Trust

New York Mortgage Trust, Inc. is a Maryland corporation that has elected to be taxed as a real estate investment trust (“REIT”). NYMT is an internally managed real estate investment trust, or REIT, which invests in mortgage-related and financial assets and targets residential mortgage loans, including loans sourced from distressed markets, multi-family CMBS, mezzanine loans and preferred equity investments to owners of multi-family properties, equity and debt securities issued by entities that invest in commercial real estate-related investments, Agency RMBS consisting of fixed-rate, adjustable-rate and hybrid adjustable-rate RMBS and Agency IOs consisting of interest only and inverse interest-only RMBS that represent the right to the interest component of the cash flow from a pool of mortgage loans. RiverBanc, LLC, The Midway Group, L.P. and Headlands Asset Management, LLC provide investment management services to the Company with respect to certain of its targeted asset classes.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to the payment of the dividends. Forward-looking statements are based on our beliefs, assumptions and expectations of our future performance, taking into account all information currently available to us.  These beliefs, assumptions and expectations are subject to risks and uncertainties and can change as a result of many possible events or factors, not all of which are known to us, including those described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014 and our Quarterly Reports on Form 10-Q for quarters ended March 31, 2015, June 30, 2015 and September 30, 2015, which have been filed with the Securities and Exchange Commission.  If a change occurs, these forward-looking statements may vary materially from those expressed in this release. All forward-looking statements speak only as of the date on which they are made. Except as required by law, we are not obligated to, and do not intend to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

For Further Information AT THE COMPANY Kristine R. Nario                                                            Chief Financial Officer                                                  Phone:  646-216-2363                                                    Email: knario@nymtrust.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LASEROPTEK Embraces CPT Clarity: Impacts on Dermatology

Updated Category News Views 130

CPT Changes: A New Era for Dermatology? Get this: the American Medical Association's revisions to the CPT codes could be just the spark LASEROPTEK's been waiting for. Landing on the desk is the 2027 Current Procedural Terminology (CPT) code set which clarifies how docs report targeted UVB laser treatments. We're talking about codes 96920–96922, now clear as crystal,...

Continue Reading
Ortho Molecular and HANS: Streamlining Functional Medicine

Updated Category News Views 33

Functional Medicine Gets a Tech Boost The world of functional medicine just got a major shot in the arm, courtesy of an intriguing alliance between Ortho Molecular Products and HANS.FM. First of all, let's address the elephant in the room: clinicians in this field aren't exactly on a coffee break. They’re buried under mountains of paperwork, often spending hours just...

Continue Reading
Edgewise Therapeutics' Investor Play: What's the Buzz?

Updated Category News Views 95

Edgewise Therapeutics Maps Out Investor Terrain Alright, Edgewise Therapeutics, folks. They're shaking things up, and I mean that literally and figuratively. This clinical-stage cardiac biotech isn’t just sitting on its hands; they're out there hustling at the Guggenheim 3rd Annual Healthcare Innovation Conference. Buckle up, because the heart of their...

Continue Reading
Hexnode XDR Expands Threat Detection, MacOS Support

Updated Category News Views 24

Hexnode XDR: A Game Changer for MacOS Threats Ever heard of Hexnode? Well, today's chat is all about them beefing up their XDR platform. They’ve sagely added support for macOS—finally given the platform some love alongside Windows. It's about time! This move is a big win for everyone whose daily grind depends on keeping threats at bay across platforms. We’re talking...

Continue Reading
ADNOC Gas Doubles Q3 Net Income, Eyes $4B Year-end

Updated Category News Views 30

ADNOC Gas Fires Up Q3 Results with a Double Income Just when you think the market's throwing curveballs, ADNOC Gas comes swinging with a solid double on their net income compared to last quarter. Now that's turning some serious heads. Cranking out $1.34 billion in net income for Q3, they've effectively doubled their performance from just the prior quarter. Operational...

Continue Reading
First Graphene Taps Deeper into US Defense Market

Updated Category News Views 109

Graphene Making Waves in Defense Fresh off the press, folks. First Graphene Limited is struttin' onto the US defense scene with a repeat order for its PureGRAPH®—a big deal in the realm of electrically conductive inks. The tally comes to around A$35,000 in an order from a longtime American customer. We're talking about inks that print circuits, sensors, and more,...

Continue Reading
2027's Top Biopharma Workplaces: Key Insights Unveiled

Updated Category News Views 264

Life Sciences Workplace Spotlight Finding a workplace that doesn't feel like it's sapping the life out of you is no mean feat these days, but BioSpace has gone ahead and compiled a list that might make the job a bit easier for those scouring the biopharma sector. The 2027 Best Places to Work list just dropped, showering accolades on 50 companies making waves for their...

Continue Reading
SOTERIA and Tempus Unite for Military Cancer Battle

Updated Category News Views 115

The Military Faces Cancer's Grasp: A New Frontline There's a battle brewing in the healthcare world, one distinctly different from the chaos of stock tickers or quarterly earnings. It's about saving lives in a space where tactical precision is everything—cancer care for U.S. military personnel and veterans. SOTERIA Precision Medicine Foundation and Tempus (NASDAQ: TEM)...

Continue Reading
VIAVI Innovates with 5G Digital Twins in UK Transport

Updated Category News Views 39

VIAVI Rides the Rails with Digital Twins The latest buzzword flashing across the tech scene? Digital twins. But VIAVI Solutions Inc. (NASDAQ: VIAV) isn’t just riding the trend; it's driving it forward. Partnering up with ORBIT, this heavy-hitter aims to redesign the digital blueprint of Blackpool's transportation system. And no, this ain't just pretty talk for...

Continue Reading
Straight-Talking Look at Zepp Health's Q3 Preview

Updated Category News Views 38

Prepping for Zepp Health's Financial Disclosure There's something about earnings season that gets the blood pumping. Maybe it’s the anticipation of numbers that can either make us jump for joy or toss us into a pit of despair. November 22 promises to be an intriguing day for folks with eyes on Zepp Health. They're set to spill the beans on their third-quarter...

Continue Reading

Top 5 Most Recently Viewed Articles

Get A Drip Names New CMO Amid Longevity Boom

Updated Category News Views 21

So, here's a curveball in the health gig—longevity's caught a second wind. And who's riding the wave? Get A Drip, the UK hotshot in the wellness league. They've just snagged Dr. Luke Pratsides as their new Chief Medical Officer. Imagine adding a sharp arrow to the quiver at a time when folks are head-over-heels for living longer and staying healthier. Longevity at the...

Continue Reading
Class Action Lawsuit Alert for Marex Group Investors - Act Now!

Updated Category News Views 157

Attention Investors: Marex Group Class Action Lawsuit Announced Investors in Marex Group plc (NASDAQ: MRX) should take note of an important development. A class action lawsuit has been initiated against Marex on behalf of those who purchased shares during the specified time frame. This legal action addresses serious allegations of financial misconduct, leading to...

Continue Reading
Navigating Political Challenges: Macron's Strategy with Barnier

Updated Category News Views 69

Understanding Barnier's New Role in French Politics After navigating the intricate Brexit negotiations, Michel Barnier has now stepped into a demanding role as Prime Minister. This position is crucial for tackling the urgent challenges within France's divided political environment. Challenges Awaiting Barnier Emmanuel Macron selected Barnier to steer his government...

Continue Reading
Verona Pharma Receives Shareholder Approval for Merck Deal

Updated Category News Views 211

Verona Pharma's Shareholders Greenlight Merck Acquisition In a significant step for Verona Pharma, shareholders have given the green light for the proposed acquisition by Merck & Co., marking a pivotal moment in the biopharmaceutical company's journey. Verona Pharma plc, listed on Nasdaq under the ticker VRNA, focuses on developing innovative therapies for chronic...

Continue Reading
2024 Luxury Resale Insights from The RealReal

Updated Category News Views 818

Insights from The RealReal's 2024 Luxury Resale Report Consumers Lead the Charge, Redefining Trends and Investing in Lasting Value The RealReal, the largest online marketplace for authenticated resale luxury goods, has unveiled its seventh annual 2024 Luxury Resale Report. This extensive report draws on 13 years of data to analyze the current state of luxury resale,...

Continue Reading